Abstract
Malignant melanoma is one of the few human cancers which continues to show an increasing incidence in Australia and other countries [1,2,3,4]. In Australia overall the incidence is now about 25 per 100,000 and in the Newcastle and Northern Coastal Regions of New South Wales 50 per 100,000 of the population [5]. Similar increases in incidence have been documented in other countries with a predominantly Caucasian population [3,6]. The seriousness of this increase is due to the propensity of melanoma to metastasize from its primary site to viscera resulting in death of the patient. Current death rates in Australia are 4.8 and 2.4 per 100,000 men and women respectively or about 800 per annum in Australia [1,3,4].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Giles G, Dwyer T, Coates M, et al. Trends in skin cancer in Australia: an overview of the available data. Trans Menzies Found 1989;15:143–7.
Giles G, Armstrong BK, Smith LR. Cancer in Australia 1982. Canberra: Australasian Association of Cancer Registries and Australian Institute of Health, 1987. National Cancer Statistics Clearing House Scientific Publication No. 1. 1987:34–35.
Grin-Jorgensen CM, Rigel DS, Friedman RJ. The Worldwide incidence of malignant melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous Melanoma. 2nd Edition. Philadelphia: Lippincott, 1992:27–39.
Jones ME, Shugg D, Dwyer T, et al. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient. Med J Aust 1982; 157:373–8.
McCredie M, Coates M, Chu S, Taylor R. Trends in cancer incidence by region in NSW 1972–1990. NSW Cancer Registry, Cancer Epidemiology Research Unit, NSW State Cancer Council, 1992.
Elwood JM, Swerdlow AJ, Cox B. Trends in incidence and mortality from cutaneous melanoma in England and Wales. Trans Menzies Found 1989;15: 131–5.
Breslow A. Tumor thickness, level of invasion and node dissection in stage 1 cutaneous melanoma. Ann Surg 1975; 182:5 72–8.
Balch CM, Soong SJ, Shaw HM, et al. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous Melanoma. Philadelphia: Lippincott, 1992:165–87.
McCarthy WH, Shaw HM. Trends in the epidemiology, diagnosis and management of melanoma. Cancer Forum 1990;14:6–10.
Little JH, Holt J, Davis N. Changing epidemiology of malignant melanoma in Queensland. Med J Aust 1980; 1:66–9.
Ring IT, Walker SM, Firman D, et al. Melanoma in Queensland. Trans Menzies Found 1989; 15:157–63.
McLeod GR. Control of melanoma in high-risk populations. In: Elwood JM, ed. Melanoma and Naevi. Pigment Cell. Vol. 9. Basel: Karger, 1988:133.
Doherty VR, MacKie RM. Experience of a public education programme on early detection of cutaneous malignant melanoma. Br Med J 1988;297:388–91.
Arundell FD. Screening for melanoma and skin cancer (letter). JAMA 1986;255:2443–4.
Berwick DM. Screening in health fairs. JAMA 1985;254:1492–8.
Koh HK, Lew RA, Prout MN. Screening for melanoma/skin cancer: theoretic and practical considerations. J Am Acad Dermatol 1989;20:159–72.
Swerdlow AJ, English J, MacKie RM, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986;292:1555–9.
Greene MH, Clark WH, Tucker MA, et al. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med 1985;312:91–7.
Holman CDJ, Armstrong BK, Heenan PJ, et al. The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent Results Cancer Res 1986; 102:18–37.
English DR, Armstrong BK. Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia. Br Med J 1988;296:1285–8.
Hiatt RA, Fireman B. The possible effect of increased surveillance on the incidence of malignant melanoma. Prev Med 1986;15:652–60.
Schneider JS, Sagebiel RW, Moore DH, Lawton GM. Melanoma surveillance and earlier diagnosis (letter) 1987;1:1435.
Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Med J Aust 1983;2:425–9.
Shaw HM, McCarthy WH, Milton GW. Melanoma: Differing clinical patterns in older men and women. Geriatric Medicine Today 1985;4:31–43.
Loggie B, Ronan SG, Bean J, Das Gupta TK. Invasive cutaneous melanoma in elderly patients. Arch Dermatol 1991;127:1188–93.
Cohen HJ, Cox E, Manton K, Woodbury M. Malignant melanoma in the elderly. J Clin Oncol 1987;5:100–6.
Cassileth BR, Clark WH, Heiberger RM, et al. Relationship between patients’ early recognition of melanoma and depth of invasion. Cancer 1982;49:198–200.
Temoshok L, D’Clemente RJ, Sweet DM, et al. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer 1984;54:3048–53.
Andersen WK, Silvers DN. ‘Melanoma’. It can’t be melanoma! JAMA 1991;266:3463–5.
Shaw HM, McGovern VJ, Milton GW, Farago GA. Cutaneous malignant melanoma: occupation and prognosis. Med J Aust 1981;l:37–8.
Girgis A, Campbell E, Redman S, Sanson-Fisher RW. Screening for melanoma: a community survey of the prevalence and predictors. Med J Aust 1991;154:338–43.
Brown R, Pang G, Husbands AJ, King MG. Suppression of immune responses to influenza virus in the respiratory tract following sleep deprivation. Regional Immunology 1989;2:321–5.
Shaw HM, Milton GW, McCarthy WH, Farago GA, Dilworth P. Effect of smoking on the recurrence of malignant melanoma. Med J Aust 1979; 1:208–9.
Shaw HM, Milton GW. Smoking and the development of métastases from malignant melanoma. Int J Cancer 1981;28:153–6.
Koh HK, Sober AJ, Day CL Jr., et al. Cigarette smoking and malignant melanoma. Cancer 1984;53:2570–3.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hersey, P., Strong, T., Grant, D., Marish, Z. (1994). Risk factors for presentation with thick primary melanoma include older age, male sex, smoking and may include occupation in certain industries. In: Gallagher, R.P., Elwood, J.M. (eds) Epidemiological Aspects of Cutaneous Malignant Melanoma. Developments in Oncology, vol 73. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2626-1_17
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2626-1_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6126-8
Online ISBN: 978-1-4615-2626-1
eBook Packages: Springer Book Archive